The president and CEO of Stockholm-based ortho tech company Össur has announced his retirement after over a quarter century of leadership. Jon Sigurdsson will be turning over the reins to successor Sveinn Sölvason, effective April 1, 2022. Sölvason has been with Össur since 2009 and has served as CFO since 2009. No new CFO has been named at this time.
CEO Change at Orthotics/Prosthetics Leader, Össur
2 min read Premium comments
Secondary#ossur#jonsigurdsson#sveinnsolvason
“I congratulate Sveinn on his appointment and look forward to working with him on the transition,” said Sigurdsson. “It has been an honor to lead Össur for the past 26 years. I have had the pleasure of working with a dedicated team of employees, customers, and end-users alike, all of whom have made Össur the successful business it is today. I look forward to watching Össur continue to flourish in the years to come.”
Össur Chairman of the Board of Directors Niels Jacobsen expressed gratitude for Sigurdsson’s leadership. “On behalf of the Board of Directors, the executive management team, and Össur’s 4,000 employees, we want to sincerely thank Jon for his leadership over his more than two and a half decades with the Company,” he said. “A steadfast leader with a strong strategic vision, Jon has successfully guided Össur since 1996.”
“Under his leadership, Össur grew from $5 million in revenue and 40 employees, to a leading global medical device company with an annual revenue of approximately $700 million and 4,000 employees.”
“In addition, Jon spearheaded more than 60 acquisitions over the years and has played an instrumental part in transforming the landscape of the orthotics and prosthetics industry. I am personally very grateful to Jon for his contribution.” Jacobsen also expressed his confidence in Sveinn. “I am grateful that Sveinn has accepted this new challenge. He has a proven track record within Össur and is poised to lead the organization to further success,” said Jacobsen.
Founded in 1971, the company now holds more than 2,000 patents and a variety of award-winning designs. Össur also participates in numerous international sustainability projects, including the UN Global Compact and the UN Sustainable Development Goals. The company is set to be carbon neutral before the end of 2021.
Sölvason told OTW, “Together with an exceptional team of Össur employees worldwide, we look forward to continuing to support a Life Without Limitations and improve people’s mobility with industry leading innovation and solutions.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.